iXgene Inc.
PrivateLast Round
Series A
Jan 5, 2023
Total Funding Raised
$4.5M
Company Overview
iXgene Inc. is a biotechnology company that develops innovative cell therapies for intractable diseases, such as malignant brain tumors, by utilizing genome-edited iPS cell-derived neural stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iXgene Inc. Comparables
Compare iXgene Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CELLeBRAIN | 80% | |
| Shinobi Therapeutics, Inc. | 79% | |
| Trogenix | 71% | |
iXgene Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 5, 2023 | ||||
| Seed | Oct 1, 2020 |
iXgene Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Series A |
| MSF Capital Partners | Series A |
| UTokyo Innovation Platform Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 43% MoM.
- Jan 5, 2023
$4.5M round led by Keio Innovation Initiative.
iXgene Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iXgene Inc.'s valuation, stock price, and market status.